sparfosic acid
Term · Oncology and biomedicine · MLC-T-ONC-016841
A stable transition state analogue for an aspartate transcarbamylase- cartalyzed reaction with antineoplastic activity. Sparfosic acid is a stable transition analogue of the activated complex for the reaction catalyzed by aspartate transcarbamylase, the first step in the pyrimidine biosynthetic pathway. This agent inhibits de novo pyrimidine biosynthesis and increases the extent to which fluorouracil metabolites are incorporated into RNA.
| Identifier | MLC-T-ONC-016841 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PALA |
| Synonyms | sparfosate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016841",
"term": "sparfosic acid",
"field": "Oncology and biomedicine",
"definition": "A stable transition state analogue for an aspartate transcarbamylase- cartalyzed reaction with antineoplastic activity. Sparfosic acid is a stable transition analogue of the activated complex for the reaction catalyzed by aspartate transcarbamylase, the first step in the pyrimidine biosynthetic pathway. This agent inhibits de novo pyrimidine biosynthesis and increases the extent to which fluorouracil metabolites are incorporated into RNA.",
"abbreviation": "PALA",
"synonyms": [
"sparfosate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/sparfosic-acid/"
}
Record 15,218 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.